CYP2D6 genotype in psychiatric patients:: Impact on haloperidol metabolism.

被引：0

作者：

Schmider, J ^{[1
]}

Sachse, C ^{[1
]}

Walter, S ^{[1
]}

Filler, D ^{[1
]}

Kaiser, R ^{[1
]}

Roots, I ^{[1
]}

Brockmöller, J ^{[1
]}

机构：

[1] Humboldt Univ, Univ Clin Charite, Inst Clin Pharmacol, Berlin, Germany

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PII51

引用

页码：185 / 185

页数：1

共 50 条

[21] Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies. [J].

Borges, S ;

Desta, Z ;

Jin, Y ;

Li, L ;

Skaar, TC ;

Flockhart, DA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) :P34-P34

[22] Impact of CYP2D6 Genotype on Paroxetine Serum Concentration [J].

Hole, Kristine ;

Haslemo, Tore ;

Molden, Espen .

THERAPEUTIC DRUG MONITORING, 2023, 45 (05) :683-688

[23] Impact of CYP2D6 genotype on postoperative tramadol analgesia [J].

Stamer, UM ;

Lehnen, K ;

Höthker, F ;

Bayerer, B ;

Wolf, S ;

Hoeft, A ;

Stuber, F .

PAIN, 2003, 105 (1-2) :231-238

[24] Metabolic genotype of schizophrenic patients and haloperidol metabolism. [J].

Schmider, J ;

Sachse, C ;

Walter, S ;

Filler, D ;

Kaiser, R ;

Roots, I ;

Brockmöller, J .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) :R162-R162

[25] Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients [J].

Suzuki, A ;

Otani, K ;

Mihara, K ;

Yasui, N ;

Kaneko, S ;

Inoue, Y ;

Hayashi, K .

PHARMACOGENETICS, 1997, 7 (05) :415-418

[26] Effect of CYP2D6*10 polymorphism on mirtazapine metabolism in Japanese psychiatric patients [J].

Watanabe, T. ;

Hyashi, Y. ;

Aoki, A. ;

Ishiguro, S. ;

Inoue, Y. ;

Akiyama, K. ;

Tsuchimine, S. ;

Yasui-Furukori, N. ;

Shimoda, K. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 :S462-S463

[27] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients [J].

Ueda, M ;

Hirokane, G ;

Morita, S ;

Okawa, M ;

Shimoda, K .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) :181-181

[28] Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression [J].

Komahashi-Sasaki, Hazuki ;

Yasui-Furukori, Norio ;

Sasaki, Taro ;

Shinozaki, Masataka ;

Hayashi, Yuki ;

Kato, Kazuko ;

Inoue, Yoshimasa ;

Tsuchimine, Shoko ;

Watanabe, Takashi ;

Sugawara, Norio ;

Shimoda, Kazutaka .

THERAPEUTIC DRUG MONITORING, 2021, 43 (05) :681-687

[29] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients [J].

Ueda, M ;

Hirokane, G ;

Morita, S ;

Yokono, A ;

Okawa, M ;

Shimoda, K .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S223-S223

[30] Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6 [J].

Ohnuma, T ;

Shibata, N ;

Matsubara, Y ;

Arai, H .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) :315-320

← 1 2 3 4 5 →